Case Reports Market Analysis and Reports | Canada Conference Series

Market Analysis - Case Reports 2018

Case Reports and its importance:

Case reports are defined as the scientific documentation of a single clinical observation and have a time-honoured and rich tradition in medicine and scientific publication. Case reports represent a relevant, timely, and important study design in advancing medical scientific knowledge especially of rare diseases. While there are clear limitations to the methodology of case studies in determination of treatment and establishment of new tests, the observation of a single patient can add to our understanding of etiology, pathogenesis, natural history, and treatment of particularly rare diseases, and to the training of potential junior investigators. In recent years this class of scientific publication has come under scrutiny and disfavour among some in the medical scientific publication community and case studies are frequently relegated to the lowest rung of the hierarchy of study design. Future research on the importance of case reports in advancing knowledge of rare diseases is recommended.

Market Trends

The increasing disease burden is propelling the pharmaceutical and biotechnology industry to bring up new chemical entities into the market at a higher rate. Most companies are outsourcing the clinical trials of their newly developed drugs to various contract research organizations as this could save them the hassles of regulatory issues and patient recruitment burden from the research and development phase. Clinical trials allow the drug to be tested for safety by different ethnic population. Due to the higher medical needs and increasing disease prevalence, developing countries are becoming a hub for clinical trial execution. Since 2006, there have been an increased number of trials registered worldwide and it is estimated to increase further in the coming years, which would contribute to the market growth. 

The United States and Canada have the highest market share in the clinical trials market, followed by Europe where Germany leads the market followed by Poland and Western Europe. Asia is one of the fastest growing markets. India, China, Singapore and South Korea are the major players involved in this market. This high growth is attributed to the fact that the cost involved in performing a trial is less and the huge domain it provides in the aspect of diseases and patients.

Industry Insights

The global clinical trials market size was valued at USD 40.0 billion in 2016 and is expected to grow at a CAGR of 5.7% over the forecast period. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and boosting demand for CROs to conduct clinical trials. CROs diversified expertise as compared to pharma companies with respect to performing clinical trials in wide array of geographies and development of drugs in specific therapeutic areas are few factors responsible for the growing demand for the CROs in pharmaceutical segment.

Global health care by the numbers

  • Global health care expenditures are projected to reach $8.7 trillion by 2020, from $7 trillion in 2015, driven by improving treatments in therapeutic areas (TA) coupled with rising labor costs and increased life expectancy.
  • Health care spending as a percentage of gross domestic product (GDP) should also rise slightly, from an estimated 10.4 % in 2015 to 10.5 % in 2020. Government health care expenditures as a percentage of GDP are projected to rise more quickly in low-income countries than other income groups.
  • Life expectancy is projected to increase by one year by 2020, which will increase the aging population (over 65 years old) by 8%, from 559 million in 2015 to 604 million in 2020.
  • Chronic diseases are on the rise, assisted by rapid urbanization, sedentary lifestyles, changing diets, and rising obesity levels. By 2020, 50% of global health care expenditures—about $4 trillion—will be spent on three leading causes of death: cardiovascular diseases, cancer and respiratory diseases.
  • China and India have the largest number of diabetes sufferers in the world, at around 110 million and 69 million, respectively. Globally, the number is expected to rise from the current 415 million to 642 million by 2040.
  • From 2015 to 2050 the prevalence of dementia is forecast to increase in every region of the world. In 2015, 46.8 million people worldwide are estimated to be living with dementia. This number is anticipated to double every 20 years, reaching 74.7 million in 2030 and 131.5 million in 2050.
  • Communicable diseases are an ongoing threat. HIV-AIDS continues to affect 36.9 million people worldwide, with around 70% of them living in Sub-Sahara Africa. The Zika virus and associated upsurge in microcephaly are major threats in Latin America.

Why Toronto?

Toronto is Canada's largest city, the fourth largest in North America, and home to a diverse population of about 2.8 million people. It's a global centre for business, finance, arts and culture and is consistently ranked one of the world's most liveable cities.

Entertainment, shopping, art and antiques, gift and souvenirs

Toronto is one of the world’s most cosmopolitan and multicultural cities, flourishing on the north-western shores of Lake Ontario is known for the diverse choice of food, arts, festivals and weather patterns. Smaller suburbs surrounding the city provide options for people who prefer to take time out from big city life. Being the fourth largest city in North America, it is most populous metropolitan of Canada, habiting about 26% of the Canadian population. English is spoken by majority of Torontonians, though there are 160 languages in the city. Toronto is an international centre of business, finance, arts, and culture. Toronto is Canada’s banking/financial capital and the home of its principle stock exchange, the Toronto Stock Exchange.

We truly hope Toronto would prove to be an amazing and comfortable experience for all the attendees.

Clinical Research Organization in Canada:

  • ADA Medical Ltd.
  • Algorithme Pharma
  • BioPharma Services Inc.
  • Niagara Clinical Research
  • Dermatrials Research Inc
  • Inflamax Research Inc.
  • KGK Science
  • LMC Diabetes & Endocrinology
  • Manna Research
  • Nutrasource Diagnostics Inc.
  • Pharmaceutical Integrated Research Corporation
  • Probity Medical Research
  • Q&T Research
  • Topstone Research
  • Toronto Memory Program
  • Trial Management Group Inc.

Top Universities in Ontario:

  • University of Toronto
  • York university
  • University of western Ontario
  • University of Waterloo
  • McMaster University
  • Queens University

Top Universities in Canada:

  • University Of British Columbia
  • McGill University
  • University OF Alberta
  • University of Manitoba College of Medicine
  • Dalhousie University Faculty of Medicine
  • Université de Montréal Faculté de Médecine

  Top universities in USA:

  • University of California
  • University of Chicago
  • Yale University
  • University of Pennsylvenia
  • Duke University
  • University of Minnesota

Top Universities around the World:

  • Cornell University
  • Harvard University
  • University of Michigan Medical School
  • Emory University
  • Thomas Jefferson University
  • University of Pittsburgh
  • Johns Hopkins Medical Institutions
  • Hospitals Associated with Dermatology Research in Toronto:
  • Sunnybrook Hospital
  • Womens college hospital
  • Mount Sinai Hospital
  • Toronto Western Hospitals

Hospitals Associated with Clinical Research in Canada:

  • Alberta Health Services
  • Hospital for Sick Children
  • Vancouver General hospital, Vancouver
  • Ottawa General Hospital, Ottawa
  • Shriners Hospital-Canada
  • Mission Memorial Hospital, Mission
  • Toronto General Hospital